These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 15165838)

  • 1. Enhanced antinociception by nicotinic receptor agonist epibatidine and adrenal medullary transplants in the spinal subarachnoid space.
    Caban AJ; Hama AT; Lee JW; Sagen J
    Neuropharmacology; 2004 Jul; 47(1):106-16. PubMed ID: 15165838
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A-85380 and epibatidine each interact with disparate spinal nicotinic receptor subtypes to achieve analgesia and nociception.
    Khan IM; Stanislaus S; Zhang L; Taylor P; Yaksh TL
    J Pharmacol Exp Ther; 2001 Apr; 297(1):230-9. PubMed ID: 11259549
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nociceptive and antinociceptive responses to intrathecally administered nicotinic agonists.
    Khan IM; Buerkle H; Taylor P; Yaksh TL
    Neuropharmacology; 1998 Dec; 37(12):1515-25. PubMed ID: 9886674
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of nicotinic acetylcholine and opioid systems of the ventral orbital cortex in modulation of formalin-induced orofacial pain in rats.
    Yousofizadeh S; Tamaddonfard E; Farshid AA
    Eur J Pharmacol; 2015 Jul; 758():147-52. PubMed ID: 25864612
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The locus coeruleus nucleus as a site of action of the antinociceptive and behavioral effects of the nicotinic receptor agonist, epibatidine.
    Cucchiaro G; Chaijale N; Commons KG
    Neuropharmacology; 2006 Jun; 50(7):769-76. PubMed ID: 16460769
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The dorsal raphe nucleus as a site of action of the antinociceptive and behavioral effects of the alpha4 nicotinic receptor agonist epibatidine.
    Cucchiaro G; Chaijale N; Commons KG
    J Pharmacol Exp Ther; 2005 Apr; 313(1):389-94. PubMed ID: 15608080
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differences between the antinociceptive effects of the cholinergic channel activators A-85380 and (+/-)-epibatidine in rats.
    Curzon P; Nikkel AL; Bannon AW; Arneric SP; Decker MW
    J Pharmacol Exp Ther; 1998 Dec; 287(3):847-53. PubMed ID: 9864263
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ABT-594 [(R)-5-(2-azetidinylmethoxy)-2-chloropyridine]: a novel, orally effective analgesic acting via neuronal nicotinic acetylcholine receptors: I. In vitro characterization.
    Donnelly-Roberts DL; Puttfarcken PS; Kuntzweiler TA; Briggs CA; Anderson DJ; Campbell JE; Piattoni-Kaplan M; McKenna DG; Wasicak JT; Holladay MW; Williams M; Arneric SP
    J Pharmacol Exp Ther; 1998 May; 285(2):777-86. PubMed ID: 9580626
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interaction between midazolam and epibatidine in spinally mediated antinociception in rats.
    Nishiyama T
    J Anesth; 2009; 23(3):370-7. PubMed ID: 19685117
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Attenuation of formalin pain responses in the rat by adrenal medullary transplants in the spinal subarachnoid space.
    Siegan JB; Sagen J
    Pain; 1997 Apr; 70(2-3):279-85. PubMed ID: 9150303
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modulatory role of estradiol in nicotinic antinociception in adult female rats.
    Chen Y; Cui Y; Lin JW; Xiang QL; Liu WF; Wang TH
    Life Sci; 2009 Jul; 85(1-2):91-6. PubMed ID: 19427872
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alterations in endogenous brain beta-endorphin release by adrenal medullary transplants in the spinal cord.
    Yadid G; Zangen A; Herzberg U; Nakash R; Sagen J
    Neuropsychopharmacology; 2000 Dec; 23(6):709-16. PubMed ID: 11063926
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adrenal medullary transplants reduce formalin-evoked c-fos expression in the rat spinal cord.
    Siegan JB; Herzberg U; Frydel BR; Sagen J
    Brain Res; 2002 Jul; 944(1-2):174-83. PubMed ID: 12106677
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neuropathy-specific analgesic action of intrathecal nicotinic agonists and its spinal GABA-mediated mechanism.
    Rashid MH; Ueda H
    Brain Res; 2002 Oct; 953(1-2):53-62. PubMed ID: 12384238
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analgesic effects of Sazetidine-A, a new nicotinic cholinergic drug.
    Cucchiaro G; Xiao Y; Gonzalez-Sulser A; Kellar KJ
    Anesthesiology; 2008 Sep; 109(3):512-9. PubMed ID: 18719450
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epibatidine binding sites and activity in the spinal cord.
    Khan IM; Yaksh TL; Taylor P
    Brain Res; 1997 Apr; 753(2):269-82. PubMed ID: 9125412
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacogenetic variability in neuronal nicotinic receptor-mediated antinociception.
    Flores CM; Wilson SG; Mogil JS
    Pharmacogenetics; 1999 Oct; 9(5):619-25. PubMed ID: 10591542
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effects of morphine, nicotine and epibatidine on lymphocyte activity and hypothalamic-pituitary-adrenal axis responses.
    Mellon RD; Bayer BM
    J Pharmacol Exp Ther; 1999 Feb; 288(2):635-42. PubMed ID: 9918569
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evidence for nicotinic receptors potentially modulating nociceptive transmission at the level of the primary sensory neuron: studies with F11 cells.
    Puttfarcken PS; Manelli AM; Arneric SP; Donnelly-Roberts DL
    J Neurochem; 1997 Sep; 69(3):930-8. PubMed ID: 9282914
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antihyperalgesic activity of epibatidine in the formalin model of facial pain.
    Gilbert SD; Clark TM; Flores CM
    Pain; 2001 Jan; 89(2-3):159-65. PubMed ID: 11166471
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.